Germ-cell tumors [5]

New England Journal of Medicine

Volumn 357, Issue 17, 2007, Pages 1771-1774

  Shamash, Jonathan ^a   Stebbing, Justin ^a   Powles, Thomas ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER SURVIVAL; DRUG MEGADOSE; GERM CELL TUMOR; HUMAN; LETTER; METASTASIS; PRIORITY JOURNAL; SCORING SYSTEM; STEM CELL TRANSPLANTATION;

EID: 35548944485     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc072495     Document Type: Letter

References (5)

1. Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 2007;357:340-8.
2. Shamash J, Powles T, Ansell W, et al. GAMEC - a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours. Br J Cancer 2007;97:308-14.
3. Shamash J, Oliver RT, Ong J, et al. Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy. Ann Oncol 1999;10:685-92.
4. Fosså SD, Stenning SP, Gerl A, et al. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer 1999;80:1392-9.
5. Motzer RJ, Mazumdar M, Sheinfeld J, et al. Sequential dose-intensive paclitaxel, ifosfamide, carboplatin and etoposide salvage therapy for germ cell tumor patients. J Clin Oncol 2000;18:1173-80.